Code | 5760D | ||||||||||
MA number | EU/1/15/1076/019 | ||||||||||
Product Form: | plv iol 30(30x1)x500 IU+2,5 ml solv. (liek.inj.skl.+adapt.+striek.inj.skl.napl.-3 ml-multibal.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Bayer AG, Germany | ||||||||||
Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 30 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - known active substance |
MA issued: | 17.09.2020 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 27.10.2020 |